The designation means the FDA will prioritize the device’s regulatory review processes, according to an Aug. 18 news release.
According to Abiomed, the Impella ECP pump is the world’s smallest heart pump that expands inside the body to support the heart’s blood flow.
Abiomed was granted the designation after reporting positive clinical data from a study of 21 patients treated with the heart pump.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
